John V. Oyler
John V. Oyler | |
|---|---|
| Born | 1968 Pittsburgh, Pennsylvania |
| Alma mater | Massachusetts Institute of Technology |
| Occupation | Businessman |
| Known for | BeiGene |
John V. Oyler (born 1968) is an American executive.[1] He is known for co-founding BeOne, a biotechnology company, with biochemist Xiaodong Wang.[2]
Early life and education
Oyler grew up in Pittsburgh, Pennsylvania. He attended the Massachusetts Institute of Technology.[3] He graduated with a degree in mechanical engineering in 1990.[2][4]
Career
Oyler began his career as a consultant at McKinsey & Company, which often involved traveled to China.[5] During his time at McKinsey, he earned an MBA degree from Stanford University and continued to work there after graduate school.[2]
Oyler joined Genta, a biotechnology company focused on cancer drugs, in 1997. At Genta, Oyler hired new management and grew the company's valuation from a few million dollars to $1.7 billion.
In 1998, Oyler was a founder of Telephia, a telecom research company where he served as president.[6][5][7] Nielsen Holdings acquired Telephia in 2007.[8] Oyler was also headed Galenea, a company focused on treatments for psychiatric diseases,[9] from 2002 to 2004.[10]
In 2005, Oyler returned to China[5] and co-founded BioDuro, a contract research organization.[9] PPD acquired BioDuro in 2009.[11]
BeiGene
Oyler co-founded BeiGene in 2010 with Chinese biochemist Xiaodong Wang, whom Oyler met while working at BioDuro.[2]
BeiGene has developed two cancer medicines, namely Tevimbra, a checkpoint inhibitor, and Brukinsa, a Bruton's tyrosine kinase inhibitor.[3] As of 2023, BeiGene had 10,000 employees.[12]
Personal life
Oyler is married and has one daughter.
See also
References
- ^ Forbes profile
- ^ a b c d Wright, Rob (1 November 2019). "How — And Why — John Oyler Built BeiGene". Life Science Leader. Retrieved 26 September 2023.
- ^ a b Henderson, Lisa (29 March 2023). "A Vision of Affordability". PharmExec. Retrieved 27 September 2023.
- ^ "Fireside chat with John Oyler". MIT Club of Hong Kong. Retrieved 27 September 2023.
- ^ a b c Saionz, Amanda (4 May 2023). "In Profile: BeiGene's John Oyler". PharmaBoardroom. Retrieved 26 September 2023.
- ^ Gregson, Reily (30 November 1999). "Telephia Hopes to Become the A.C. Nielsen of Wireless World". RCR Wireless News. Retrieved 26 September 2023.
- ^ Gregson, Reily (30 November 1999). "Telephia expands into untethered Internet access monitoring". RCR Wireless News. Retrieved 26 September 2023.
- ^ Learmonth, Michael (28 June 2007). "Nielsen nabs Telephia". Variety. Retrieved 18 December 2023.
- ^ a b Jia, Hepeng (19 May 2008). "China's one stop research shop". Chemistry World. Retrieved 26 September 2023.
- ^ "John V. Oyler". The Medicine Maker. 2022. Retrieved 27 September 2023.
- ^ "PPD Buys BioDuro For $77 Million". Manufacturing.net. Associated Press. 30 November 2009. Retrieved 26 September 2023.
- ^ "Form 10-Q". BeiGene. 30 June 2023. Retrieved 15 August 2023.